Ferric ferrocyanide is a decorporation agent indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium, in order to increase their rates of elimination. MedsAcross supplies Ferric ferrocyanide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Radiogardase is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium, in order to increase their rates of elimination. Radiogardase is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.
Source: US FDA prescribing information
Prussian blue insoluble, ferric hexacyanoferrate(II), acts by ion-exchange, adsorption, and mechanical trapping within the crystal structure, and has a high affinity for radioactive and non-radioactive cesium and thallium. Prussian blue insoluble binds cesium and thallium isotopes in the gastrointestinal tract after these isotopes are ingested or excreted in the bile by the liver, thereby reducing gastrointestinal reabsorption (enterohepatic circulation). The rate of cesium and thallium elimination is proportional to the duration and dose of prussian blue insoluble.
Source: US FDA prescribing information
Adults and Adolescents: 3 grams orally three times a day. Pediatrics (2 – 12 years): 1 gram orally three times a day. Administer as soon as possible after internal contamination with cesium or thallium is suspected
Source: US FDA prescribing information
None None
Source: US FDA prescribing information
Increased radiation absorbed dose to gastrointestinal mucosa: Monitor for decreased gastrointestinal motility. Constipation: Monitor and treat. Electrolyte abnormalities: Monitor serum electrolytes during treatment. Blue discoloration of stool, oral mucosa and dentition
Source: US FDA prescribing information
Constipation was reported in 10 (24%) of 42 patients treated with Radiogardase. Severity of constipation was mild in 7 patients and moderate in 3 patients. Most common adverse reaction (incidence >24%) was constipation
Source: US FDA prescribing information
Based on animal data, co-administration of Radiogardase with other decorporation agents does not affect the efficacy of Radiogardase for treatment of internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium.
Source: US FDA prescribing information
Storage Store at 20 °C to 25 °C (68 °F to 77 °F), excursions permitted between 15 °C and 30°C (between 59 °F and 86 °F). Brief exposure to temperatures up to 40 °C (104 °F) may be tolerated, provided the mean kinetic temperature does not exceed 25 °C (77 °F), however, minimize such exposure.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Ferric ferrocyanide, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Radiogardase 500 mg capsuleOral | Heyl Chem.-pharm. Fabrik | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Ferric ferrocyanide in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 1 presentations of Ferric ferrocyanide and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Ferric ferrocyanide, including Radiogardase.
No listed presentation of Ferric ferrocyanide is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Ferric ferrocyanide is classified under ATC code V03AB31 (Ferric ferrocyanide).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.